anti-Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 (MLL2) 抗体产品概述

Full name:
anti-Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 抗体 (MLL2)
在www.antibodies-online.cn可供35 Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 (MLL2) 抗体的10不同的供货商。 再加上,我们可以发Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 试剂盒 (10)和数多这个蛋白质的别的产品。 总共47 Myeloid/lymphoid Or Mixed-Lineage Leukemia 2产品已列进来了。
别名:
AAD10, ALR, BC032281, BC058659, C430014K11Rik, CAGL114, GSTO1, HRX2, im:7157663, KABUK1, KMS, KMT2B, MLL1B, Mll2, Mll4, TNRC21, TRX2, WBP7

最受欢迎的抗anti-Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 (MLL2) 抗体

选择您的来源和应用

抗Rat (Rattus) 抗体:

抗Human 抗体:

抗Mouse (Murine) 抗体:

所有可销售的anti-Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 抗体

您会转到已过滤好的搜索

引用最多的anti-Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 抗体

  1. Human Polyclonal MLL2 Primary Antibody for IHC, ELISA - ABIN184880 : Prasad, Zhadanov, Sedkov, Bullrich, Druck, Rallapalli, Yano, Alder, Croce, Huebner, Mazo, Canaani: Structure and expression pattern of human ALR, a novel gene with strong homology to ALL-1 involved in acute leukemia and to Drosophila trithorax. in Oncogene 1997 (PubMed)

  2. Human Monoclonal MLL2 Primary Antibody for ELISA, WB - ABIN948660 : Micale, Augello, Maffeo, Selicorni, Zucchetti, Fusco, De Nittis, Pellico, Mandriani, Fischetto, Boccone, Silengo, Biamino, Perria, Sotgiu, Serra, Lapi, Neri, Ferlini, Cavaliere, Chiurazzi, Monica et al.: Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of Kabuki syndrome patients. ... in Human mutation 2014 (PubMed)

更多抗Myeloid/lymphoid Or Mixed-Lineage Leukemia 2的相互作用对抗体

Human Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 (MLL2) interaction partners

  1. Three of four cases of histiocytic sarcoma had alterations in the KMT2D gene.

  2. Study shows the contribution of MLL2's methyltransferase and CXXC domain in the trimethylation of H3K4 in embryonic stem cells and find that while it trimethylates H3K4 at both bivalent gene promoters and non-TSS (显示 RPL38 抗体) elements, it regulates transcription at a limited number of genes including those required for primordial germ cell specification.

  3. KMT2D Mutation is associated with esophageal squamous cell carcinoma.

  4. The crucial role of KMT2B in the physiological control of voluntary movement.

  5. MLL1 and MLL2 collaborate to regulate gene expression and leukemia maintenance not through redundancy, but through distinct pathways.

  6. Our findings provide evidence that CHARGE and Kabuki syndromes result from dysregulatrion of CHD7 (显示 CHD7 抗体) and KMT2D genes involved embryonal development that are expressed in a tissue-specific manner.

  7. we demonstrate that low KMT2C and KMT2D expression in biopsies defines better outcome groups in pancreatic ductal adenocarcinoma

  8. MLL4 mutation along with BRCA1 mutation confers chemoresistance in breast cancer.

  9. Pathogenic variants in KMT2D resulting in protein truncation in 43% (6/14; of which 3 are novel) of all cases were detected, while analysis of KDM6A (显示 KDM6A 抗体) was negative. MLPA analysis was negative in all instances.

  10. Results show that KMT2B interacts with ERalpha (显示 ESR1 抗体) to bind the ERalpha (显示 ESR1 抗体)-binding sites of IL-20 (显示 IL20 抗体) and other ERalpha (显示 ESR1 抗体) target genes with H3K4 modifications suggesting an important role for KMT2B in the epigenetic transcriptional regulation of cytokine IL-20 (显示 IL20 抗体), and other ERalpha (显示 ESR1 抗体)-responsive genes, in breast cancer cells.

Mouse (Murine) Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 (MLL2) interaction partners

  1. UTX (显示 KDM6A 抗体)-MLL4 (显示 MLL4 抗体)-p300 (显示 NOTCH1 抗体) transcriptional regulatory network establishing an "active enhancer landscape" and defines a detailed mechanism for the joint deposition of H3K4me1 and H3K27ac.

  2. MLL4 (显示 MLL4 抗体) deficiency compromised the development of regulatory T cells (Treg cells) and resulted in a substantial decrease in monomethylated H3K4 (H3K4me1) and chromatin interaction at putative gene enhancers, a considerable portion of which were not direct targets of MLL4 (显示 MLL4 抗体) but were enhancers that interacted with MLL4 (显示 MLL4 抗体)-bound sites.

  3. Study shows the contribution of MLL2 (显示 MLL4 抗体)'s methyltransferase and CXXC domain in the trimethylation of H3K4 in embryonic stem cells and find that while it trimethylates H3K4 at both bivalent gene promoters and non-TSS (显示 RPL38 抗体) elements, it regulates transcription at a limited number of genes including those required for primordial germ cell specification.

  4. While H3K4me1 partially supports H3K27ac at active enhancers, it is largely dispensable for transcription. By contrast, Mll3/4 proteins themselves are required for enhancer Pol II loading, eRNA synthesis, and gene expression.

  5. Data from MLL4/KMT2D enzyme-dead knockin ES cells and mice indicate that the enzymatic activity of H3K4 methyltransferase MLL4 (显示 MLL4 抗体) is required for its protein stability.

  6. Although enhancer priming by H3K4me1/2 methyltransferase MLL4/KMT2D is dispensable for cell-identity maintenance, it controls cell fate transition by orchestrating p300 (显示 NOTCH1 抗体)-mediated enhancer activation

  7. KMT2D is essential for regulating cardiac gene expression during heart development primarily via H3K4 di-methylation

  8. MLL2 interacts with RNA polymerase II (RNAPII) and RECQL5, and, although MLL2 mutated cells have normal overall H3K4me levels in genes, nucleosomes in the immediate vicinity of RNAPII are hypomethylated.

  9. MLL4 (KMT2D) is a major H3K4 mono- and di-methyltransferase with partial functional redundancy with MLL3 (KMT2C) in mouse and human cells. MLL4 is enriched on enhancers and is required for enhancer activation, cell-type-specific gene expression and cell differentiation.

  10. Both MLL3 and MLL4 (显示 MLL4 抗体) complexes act as major epigenetic regulators of diverse metabolic processes (including circadian control of bile acid homeostasis).

Pig (Porcine) Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 (MLL2) interaction partners

  1. MLL2 is essential for porcine embryo development by the regulation of methylation of H3K4 in vitro.

Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 (MLL2) 抗原简介

Antigen Summary

The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome.

Alternative names and synonyms associated with Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 (MLL2)

  • lysine (K)-specific methyltransferase 2D (kmt2d) 抗体
  • glutathione S-transferase omega-1-like (LOC785216) 抗体
  • growth factor, augmenter of liver regeneration (Gfer) 抗体
  • lysine (K)-specific methyltransferase 2B (KMT2B) 抗体
  • lysine (K)-specific methyltransferase 2D (Kmt2d) 抗体
  • lysine (K)-specific methyltransferase 2D (KMT2D) 抗体
  • myeloid/lymphoid or mixed-lineage leukemia 2 (MLL2) 抗体
  • myeloid/lymphoid or mixed-lineage leukemia 2-like (Mll2l) 抗体
  • AAD10 抗体
  • ALR 抗体
  • BC032281 抗体
  • BC058659 抗体
  • C430014K11Rik 抗体
  • CAGL114 抗体
  • GSTO1 抗体
  • HRX2 抗体
  • im:7157663 抗体
  • KABUK1 抗体
  • KMS 抗体
  • KMT2B 抗体
  • MLL1B 抗体
  • Mll2 抗体
  • Mll4 抗体
  • TNRC21 抗体
  • TRX2 抗体
  • WBP7 抗体

Protein level used designations for MLL2

myeloid/lymphoid or mixed-lineage leukemia 2 , glutathione S-transferase omega 1 , FAD-linked sulfhydryl oxidase ALR , augmenter of liver regeneration , growth factor, erv1 homolog , growth factor, erv1-like (augmenter of liver regeneration) , KMT2D , WBP-7 , WW domain binding protein 7 , WW domain-binding protein 7 , histone-lysine N-methyltransferase 2B , histone-lysine N-methyltransferase MLL4 , lysine N-methyltransferase 2B , lysine N-methyltransferase 2D , mixed lineage leukemia gene homolog 2 , myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) 4 , myeloid/lymphoid or mixed-lineage leukemia 4 , myeloid/lymphoid or mixed-lineage leukemia protein 4 , trithorax homolog 2 , trithorax homologue 2 , ALL1-related protein , histone-lysine N-methyltransferase 2D , histone-lysine N-methyltransferase MLL2 , myeloid/lymphoid or mixed-lineage leukemia protein 2 , Kabuki make-up syndrome , Kabuki mental retardation syndrome , trinucleotide repeat containing 21

GENE ID SPECIES
100158249 Danio rerio
785216 Bos taurus
27100 Rattus norvegicus
9757 Homo sapiens
381022 Mus musculus
8085 Homo sapiens
506805 Bos taurus
100512962 Sus scrofa
486558 Canis lupus familiaris
425846 Gallus gallus
362996 Rattus norvegicus
anti-Myeloid/lymphoid Or Mixed-Lineage Leukemia 2 (MLL2) 抗体 精选生产商
您还需要查找其他产品吗?